JPH05501728A - キノリン誘導体の製法 - Google Patents

キノリン誘導体の製法

Info

Publication number
JPH05501728A
JPH05501728A JP3513216A JP51321691A JPH05501728A JP H05501728 A JPH05501728 A JP H05501728A JP 3513216 A JP3513216 A JP 3513216A JP 51321691 A JP51321691 A JP 51321691A JP H05501728 A JPH05501728 A JP H05501728A
Authority
JP
Japan
Prior art keywords
formula
alkyl
ethyl
methyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3513216A
Other languages
English (en)
Japanese (ja)
Inventor
ラトクリフ，アーノルド　ハリー
ウィリアムズ，エミール　グリン
Original Assignee
インペリアル　ケミカル　インダストリーズ　ピーエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インペリアル　ケミカル　インダストリーズ　ピーエルシー filed Critical インペリアル　ケミカル　インダストリーズ　ピーエルシー
Publication of JPH05501728A publication Critical patent/JPH05501728A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP3513216A 1990-08-09 1991-07-30 キノリン誘導体の製法 Pending JPH05501728A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9017479.8 1990-08-09
GB909017479A GB9017479D0 (en) 1990-08-09 1990-08-09 Process

Publications (1)

Publication Number Publication Date
JPH05501728A true JPH05501728A (ja) 1993-04-02

Family

ID=10680406

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3513216A Pending JPH05501728A (ja) 1990-08-09 1991-07-30 キノリン誘導体の製法

Country Status (15)

Country Link
EP (1) EP0495948A1 (cs)
JP (1) JPH05501728A (cs)
KR (1) KR920702357A (cs)
CN (1) CN1058965A (cs)
AU (1) AU8309091A (cs)
CA (1) CA2047249A1 (cs)
CS (1) CS88692A3 (cs)
FI (1) FI921319A0 (cs)
GB (2) GB9017479D0 (cs)
HU (1) HUT60490A (cs)
IE (1) IE912406A1 (cs)
IL (1) IL98833A0 (cs)
PT (1) PT98607A (cs)
WO (1) WO1992002508A1 (cs)
ZA (1) ZA915567B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246944A (en) * 1991-08-13 1993-09-21 Merck & Co., Inc. Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
US5484955A (en) * 1992-07-06 1996-01-16 Takeda Chemical Industries, Ltd. Tri-higher alkyl tin azide and its use
US6608048B2 (en) 2000-03-28 2003-08-19 Wyeth Holdings Tricyclic protein kinase inhibitors
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
RS60093B1 (sr) 2013-09-16 2020-05-29 Astrazeneca Ab Terapeutske polimerne nanočestice i postupci njihove pripreme i primene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
EP0412848B1 (en) * 1989-08-11 1995-01-18 Zeneca Limited Quinoline derivatives, process for their preparation and their use as medicaments

Also Published As

Publication number Publication date
CN1058965A (zh) 1992-02-26
AU8309091A (en) 1992-03-02
PT98607A (pt) 1992-06-30
IL98833A0 (en) 1992-07-15
CS88692A3 (en) 1992-10-14
FI921319L (fi) 1992-03-26
GB9017479D0 (en) 1990-09-26
EP0495948A1 (en) 1992-07-29
FI921319A7 (fi) 1992-03-26
HU9200933D0 (en) 1992-05-28
GB9115250D0 (en) 1991-08-28
WO1992002508A1 (en) 1992-02-20
IE912406A1 (en) 1992-02-12
CA2047249A1 (en) 1992-02-10
KR920702357A (ko) 1992-09-03
HUT60490A (en) 1992-09-28
FI921319A0 (fi) 1992-03-26
ZA915567B (en) 1992-07-29

Similar Documents

Publication Publication Date Title
AU646473B2 (en) Process for the manufacture of biphenylcarbonitriles
US5126344A (en) Diazine derivatives and pharmaceutical use
US5294620A (en) 1,6-naphthyridinone derivatives having angiotension II antagonist activity
US5444071A (en) Quinoline derivatives and use thereof as angiotensin II antagonists
JPH04244080A (ja) ビフエニルカルボニトリルの製法
CA2032831A1 (en) Fused imidazole derivatives, their production and use
US5236937A (en) Pyridinyl compounds which are useful as angiotensin ii antagonists
JPH06505715A (ja) 化合物
JPH05501728A (ja) キノリン誘導体の製法
US5245035A (en) Heterocyclic boron compounds as intermediates for angiotensin ii antagonists
US5369114A (en) Biphenylene branched alkyleneoxy quinolines
FR2684672A1 (fr) Derives de pyrimidine, utiles pour le traitement d'etats tels que l'hypertension et l'insuffisance cardiaque, et procede pour leur preparation.
EP0511791A2 (en) Pyrrolopyridine derivatives as Angiotensin inhibitors
US5373015A (en) Fused pyridine derivatives useful as angiotensin II antagonists
JPH04346980A (ja) ４−ピリミジノン誘導体、その製造方法および治療への適用
JP2019520359A (ja) ビアリール尿素誘導体またはそれらの塩、およびそれらの調製方法および使用
IE72508B1 (en) Process for the preparation of the dextrorotatory isomer of a 2-aminonaphthyridine derivative
WO1994011379A1 (en) Heterocyclic compounds as angiotensin ii antagonists
US4318909A (en) Benzoxazocines
GB2067555A (en) Benzoxazocines